Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.

Proceedings of the National Academy of Sciences of the United States of America
Stephen J McPhersonGail P Risbridger

Abstract

Prostate cancer (PCa) and benign prostatic hyperplasia (BPH) are androgen-dependent diseases commonly treated by inhibiting androgen action. However, androgen ablation or castration fail to target androgen-independent cells implicated in disease etiology and recurrence. Mechanistically different to castration, this study shows beneficial proapoptotic actions of estrogen receptor-beta (ERbeta) in BPH and PCa. ERbeta agonist induces apoptosis in prostatic stromal, luminal and castrate-resistant basal epithelial cells of estrogen-deficient aromatase knock-out mice. This occurs via extrinsic (caspase-8) pathways, without reducing serum hormones, and perturbs the regenerative capacity of the epithelium. TNFalpha knock-out mice fail to respond to ERbeta agonist, demonstrating the requirement for TNFalpha signaling. In human tissues, ERbeta agonist induces apoptosis in stroma and epithelium of xenografted BPH specimens, including in the CD133(+) enriched putative stem/progenitor cells isolated from BPH-1 cells in vitro. In PCa, ERbeta causes apoptosis in Gleason Grade 7 xenografted tissues and androgen-independent cells lines (PC3 and DU145) via caspase-8. These data provide evidence of the beneficial effects of ERbeta agonist on epit...Continue Reading

References

Jul 1, 1996·Differentiation; Research in Biological Diversity·S W HaywardG R Cunha
Apr 1, 1997·British Journal of Urology·S W HaywardG R Cunha
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·C R FisherE R Simpson
Apr 12, 2002·Trends in Endocrinology and Metabolism : TEM·Renea A JarredGail P Risbridger
Oct 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Zhang WeihuaJan-Ake Gustafsson
Feb 10, 2004·Journal of Molecular Endocrinology·P BalanathanG P Risbridger
Jun 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Otabek ImamovJan-Ake Gustafsson
Jul 1, 2004·Journal of Cell Science·Gavin D RichardsonAnne T Collins
Feb 24, 2005·Cancer Biology & Therapy·Zhaoyu Jin, Wafik S El-Deiry
Dec 3, 2005·Cancer Research·Anne T CollinsNorman J Maitland
Mar 24, 2006·Biochemical Pharmacology·Aurélie EscandePatrick Balaguer
Jul 6, 2007·Nature Reviews. Cancer·Stuart J Ellem, Gail P Risbridger
Dec 7, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·William A RickeGail P Risbridger
May 29, 2008·Journal of the National Cancer Institute·Sunita R SetlurMark A Rubin
Jun 19, 2008·Differentiation; Research in Biological Diversity·Stephen J McPhersonGail P Risbridger
Oct 24, 2008·Nature·Kevin G LeongWei-Qiang Gao
Dec 3, 2008·Cancer Research·Donald J Vander GriendJohn T Isaacs

❮ Previous
Next ❯

Citations

Jun 1, 2012·Archives of Toxicology·Katherine A Burns, Kenneth S Korach
Jul 16, 2011·Hormones & Cancer·Norman J MaitlandAnne T Collins
Sep 17, 2011·Nature Reviews. Drug Discovery·Stefan NilssonJan-Åke Gustafsson
Jun 19, 2013·Prostate Cancer and Prostatic Diseases·M GargS N Sankhwar
Dec 3, 2011·Cancer Prevention Research·Mara H ShermanRonald M Evans
Dec 22, 2011·Chemistry Central Journal·Natalia Yu AnisimovaAndrei A Gakh
Apr 12, 2012·Endocrinology·Valeria BenedusiAdriana Maggi
Oct 10, 2013·Histochemistry and Cell Biology·Rafaela Rosa-RibeiroHernandes F Carvalho
Oct 15, 2010·Bioscience, Biotechnology, and Biochemistry·Masao YamasakiKazuo Nishiyama
Jan 10, 2014·Endocrine-related Cancer·Adam W NelsonJason S Carroll
Jun 19, 2014·Endocrine-related Cancer·Teresa EloPirkko Härkönen
May 23, 2012·Expert Opinion on Emerging Drugs·Giovanni CoronaMario Maggi
Jan 15, 2015·Annual Review of Medicine·Ellis R Levin
Dec 8, 2015·Experimental and Therapeutic Medicine·Su Kang KimYoung Ock Kim
Apr 8, 2015·Proceedings of the National Academy of Sciences of the United States of America·Laure ManeixJan-Åke Gustafsson
Mar 10, 2016·Nature Reviews. Urology·Daniel A GalvãoRobert U Newton
Apr 16, 2016·Nature Reviews. Cancer·Andrea ClocchiattiG Paolo Dotto
Jan 7, 2014·Journal of Zhejiang University. Science. B·Juliana FelgueirasMargarida Fardilha
Apr 30, 2016·Scientific Reports·Gangadhara R SareddyRatna K Vadlamudi
Sep 6, 2011·Endocrinology and Metabolism Clinics of North America·Shuk-Mei HoYuet-Kin Leung
Jun 28, 2015·Gynecologic Oncology·Michel van KruchtenAnna Reyners
Aug 17, 2016·International Journal of Molecular Sciences·Letteria MinutoliAntonio Micali
Feb 22, 2012·The Journal of Steroid Biochemistry and Molecular Biology·R ToivanenG P Risbridger
Jan 14, 2017·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Bernice AsieduGeorge A Asare
Apr 17, 2017·Biochemical and Biophysical Research Communications·Deng-Liang YangWen-Liang Zhou
Nov 29, 2015·Chinese Journal of Natural Medicines·Gangadhara R Sareddy, Ratna K Vadlamudi
May 26, 2017·Physiological Reviews·Paul S CookeRex A Hess
Aug 26, 2017·Journal of Cellular and Molecular Medicine·Bruno D A SanchesSebastião R Taboga
Jan 14, 2011·Nature Reviews. Urology·Clement K M Ho, Fouad K Habib
Feb 3, 2018·American Journal of Respiratory Cell and Molecular Biology·Andrea L FrumpTim Lahm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis